ReP USP - Resultado da busca

Artigo de periodico
Histopathological correlates of global and segmental left ventricular systolic dysfunction in experimental chronic chagas cardiomyopathy (2016)
Oliveira, Luciano Fonseca Lemos de; Romano, Minna Moreira Dias; Carvalho, Eduardo Elias Vieira de; Cabeza, Jorge Mejia; Salgado, Hélio César; Fazan Júnior, Rubens; Costa, Renata Sesti; Silva, João Santana da; Higuchi, Maria de Lourdes; Maciel, Benedito Carlos; Cunha Neto, Edécio; Marin Neto, José Antonio; Simões, Marcus Vinicius
Source: Journal of the American Heart Association. Unidades: FMRP, FM
Subjects: INSUFICIÊNCIA CARDÍACA, DOENÇA DE CHAGAS, ECOCARDIOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Luciano Fonseca Lemos de et al. Histopathological correlates of global and segmental left ventricular systolic dysfunction in experimental chronic chagas cardiomyopathy. Journal of the American Heart Association, v. 5, n. 1, p. e002786-1 - e002786-11, 2016Tradução . . Disponível em: https://doi.org/10.1161/jaha.115.002786. Acesso em: 19 nov. 2024.
APA
Oliveira, L. F. L. de, Romano, M. M. D., Carvalho, E. E. V. de, Cabeza, J. M., Salgado, H. C., Fazan Júnior, R., et al. (2016). Histopathological correlates of global and segmental left ventricular systolic dysfunction in experimental chronic chagas cardiomyopathy. Journal of the American Heart Association, 5( 1), e002786-1 - e002786-11. doi:10.1161/jaha.115.002786
NLM
Oliveira LFL de, Romano MMD, Carvalho EEV de, Cabeza JM, Salgado HC, Fazan Júnior R, Costa RS, Silva JS da, Higuchi M de L, Maciel BC, Cunha Neto E, Marin Neto JA, Simões MV. Histopathological correlates of global and segmental left ventricular systolic dysfunction in experimental chronic chagas cardiomyopathy [Internet]. Journal of the American Heart Association. 2016 ; 5( 1): e002786-1 - e002786-11.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1161/jaha.115.002786
Vancouver
Oliveira LFL de, Romano MMD, Carvalho EEV de, Cabeza JM, Salgado HC, Fazan Júnior R, Costa RS, Silva JS da, Higuchi M de L, Maciel BC, Cunha Neto E, Marin Neto JA, Simões MV. Histopathological correlates of global and segmental left ventricular systolic dysfunction in experimental chronic chagas cardiomyopathy [Internet]. Journal of the American Heart Association. 2016 ; 5( 1): e002786-1 - e002786-11.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1161/jaha.115.002786
Artigo de periodico
Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial (2013)
Moreira, Otacilio C; Ramírez, Juan David; Velázquez, Elsa; Melo, Myllena F. A. Dias; Lima-Ferreira, Carolina; Guhl, Felipe; Sosa-Estani, Sergio; Marin Neto, Jose Antonio; Morillo, Carlos A; Britto, Constança
Source: Acta Tropica. Unidade: FMRP
Subjects: DOENÇA DE CHAGAS (ESTUDO), MIOCARDIOPATIA CHAGÁSICA, TRYPANOSOMA CRUZI, DNA (EXTRAÇÃO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Otacilio C et al. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial. Acta Tropica, v. 125, n. 1, p. 23-31, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.actatropica.2012.08.020. Acesso em: 19 nov. 2024.
APA
Moreira, O. C., Ramírez, J. D., Velázquez, E., Melo, M. F. A. D., Lima-Ferreira, C., Guhl, F., et al. (2013). Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial. Acta Tropica, 125( 1), 23-31. doi:10.1016/j.actatropica.2012.08.020
NLM
Moreira OC, Ramírez JD, Velázquez E, Melo MFAD, Lima-Ferreira C, Guhl F, Sosa-Estani S, Marin Neto JA, Morillo CA, Britto C. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial [Internet]. Acta Tropica. 2013 ; 125( 1): 23-31.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.actatropica.2012.08.020
Vancouver
Moreira OC, Ramírez JD, Velázquez E, Melo MFAD, Lima-Ferreira C, Guhl F, Sosa-Estani S, Marin Neto JA, Morillo CA, Britto C. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial [Internet]. Acta Tropica. 2013 ; 125( 1): 23-31.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.actatropica.2012.08.020
Artigo de periodico
Effects of dalcetrapib in patients with a recent acute coronary syndrome (2012)
Schwartz, Gregory G; Olsson, Anders G; Abt, Markus; Ballantyne, Christie M; Barter, Philip J; Brumm, Jochen; Chaitman, Bernard R; Holme, Ingar M; Kallend, David; Leiter, Lawrence A; Leitersdorf, Eran; McMurray, John J. V; Mundl, Hardi; Nicholls, Stephen J; Shah, Prediman K; Tardif, Jean-Claude; Wright, R. Scott; Marin Neto, Jose Antonio
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: CORONARIOPATIA, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHWARTZ, Gregory G et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. The New England Journal of Medicine, v. 367, n. 22, p. 2089-2099, 2012Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1206797. Acesso em: 19 nov. 2024.
APA
Schwartz, G. G., Olsson, A. G., Abt, M., Ballantyne, C. M., Barter, P. J., Brumm, J., et al. (2012). Effects of dalcetrapib in patients with a recent acute coronary syndrome. The New England Journal of Medicine, 367( 22), 2089-2099. doi:10.1056/NEJMoa1206797
NLM
Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJV, Mundl H, Nicholls SJ, Shah PK, Tardif J-C, Wright RS, Marin Neto JA. Effects of dalcetrapib in patients with a recent acute coronary syndrome [Internet]. The New England Journal of Medicine. 2012 ; 367( 22): 2089-2099.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1056/NEJMoa1206797
Vancouver
Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJV, Mundl H, Nicholls SJ, Shah PK, Tardif J-C, Wright RS, Marin Neto JA. Effects of dalcetrapib in patients with a recent acute coronary syndrome [Internet]. The New England Journal of Medicine. 2012 ; 367( 22): 2089-2099.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1056/NEJMoa1206797
Artigo de periodico
Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial (2010)
Gerstein, Hertzel C.; Ratner, Robert E.; Cannon, Christopher P.; Serruys, Patrick W.; García-García, Héctor M.; Es, Gerrit-Anne van; Kolatkar, Nikheel S.; Kravitz, Barbara G.; Miller, Diane M.; Huang, Chun; Fitzgerald, Peter J.; Nesto, Richard W.; Marin Neto, Jose Antonio
Source: Circulation. Unidade: FMRP
Subjects: ULTRASSONOGRAFIA, DIABETES MELLITUS, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GERSTEIN, Hertzel C. et al. Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. Circulation, v. 121, n. 10, p. 1176-1187, 2010Tradução . . Acesso em: 19 nov. 2024.
APA
Gerstein, H. C., Ratner, R. E., Cannon, C. P., Serruys, P. W., García-García, H. M., Es, G. -A. van, et al. (2010). Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. Circulation, 121( 10), 1176-1187.
NLM
Gerstein HC, Ratner RE, Cannon CP, Serruys PW, García-García HM, Es G-A van, Kolatkar NS, Kravitz BG, Miller DM, Huang C, Fitzgerald PJ, Nesto RW, Marin Neto JA. Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. Circulation. 2010 ; 121( 10): 1176-1187.[citado 2024 nov. 19 ]
Vancouver
Gerstein HC, Ratner RE, Cannon CP, Serruys PW, García-García HM, Es G-A van, Kolatkar NS, Kravitz BG, Miller DM, Huang C, Fitzgerald PJ, Nesto RW, Marin Neto JA. Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. Circulation. 2010 ; 121( 10): 1176-1187.[citado 2024 nov. 19 ]
Artigo de periodico
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes (2010)
Bassand, Jean-Pierre; Chrolavicius, Susan; Diaz, Rafael; Eikelboom, John W.; Fox, Keith A. A.; Granger, Christopher B.; Jolly, Sanjit; Marin Neto, Jose Antonio
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: FÁRMACOS, CARDIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASSAND, Jean-Pierre et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. The New England Journal of Medicine, v. 363, n. 10, p. 930-942, 2010Tradução . . Acesso em: 19 nov. 2024.
APA
Bassand, J. -P., Chrolavicius, S., Diaz, R., Eikelboom, J. W., Fox, K. A. A., Granger, C. B., et al. (2010). Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. The New England Journal of Medicine, 363( 10), 930-942.
NLM
Bassand J-P, Chrolavicius S, Diaz R, Eikelboom JW, Fox KAA, Granger CB, Jolly S, Marin Neto JA. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. The New England Journal of Medicine. 2010 ; 363( 10): 930-942.[citado 2024 nov. 19 ]
Vancouver
Bassand J-P, Chrolavicius S, Diaz R, Eikelboom JW, Fox KAA, Granger CB, Jolly S, Marin Neto JA. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. The New England Journal of Medicine. 2010 ; 363( 10): 930-942.[citado 2024 nov. 19 ]
Artigo de periodico
Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52 693 patients in the Global Registry of Acute Coronary Events (2010)
Ambrosio, Giuseppe; Del Pinto, Maurizio; Tritto, Isabella; Agnelli, Giancarlo; Bentivoglio, Maurizio; Zuchi, Cinzia; Anderson, Frederick A.; Gore, Joel M.; López-Sendón, Jose; Wyman, Allison; Kennelly, Brian M.; Fox, Keith A. A.; Marin Neto, Jose Antonio; Pazin Filho, Antonio
Source: European Heart Journal. Unidade: FMRP
Subjects: ISQUEMIA MIOCÁRDICA, NITRATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMBROSIO, Giuseppe et al. Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52 693 patients in the Global Registry of Acute Coronary Events. European Heart Journal, v. 31, n. 4, p. 430-438, 2010Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehp457. Acesso em: 19 nov. 2024.
APA
Ambrosio, G., Del Pinto, M., Tritto, I., Agnelli, G., Bentivoglio, M., Zuchi, C., et al. (2010). Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52 693 patients in the Global Registry of Acute Coronary Events. European Heart Journal, 31( 4), 430-438. doi:10.1093/eurheartj/ehp457
NLM
Ambrosio G, Del Pinto M, Tritto I, Agnelli G, Bentivoglio M, Zuchi C, Anderson FA, Gore JM, López-Sendón J, Wyman A, Kennelly BM, Fox KAA, Marin Neto JA, Pazin Filho A. Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52 693 patients in the Global Registry of Acute Coronary Events [Internet]. European Heart Journal. 2010 ; 31( 4): 430-438.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/eurheartj/ehp457
Vancouver
Ambrosio G, Del Pinto M, Tritto I, Agnelli G, Bentivoglio M, Zuchi C, Anderson FA, Gore JM, López-Sendón J, Wyman A, Kennelly BM, Fox KAA, Marin Neto JA, Pazin Filho A. Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52 693 patients in the Global Registry of Acute Coronary Events [Internet]. European Heart Journal. 2010 ; 31( 4): 430-438.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/eurheartj/ehp457
Artigo de periodico
Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification (2009)
Rassi Júnior, Anis; Rassi, Anis; Marin Neto, Jose Antonio
Source: Memórias do Instituto Oswaldo Cruz. Unidade: FMRP
Subjects: DOENÇA DE CHAGAS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RASSI JÚNIOR, Anis e RASSI, Anis e MARIN NETO, Jose Antonio. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Memórias do Instituto Oswaldo Cruz, v. 104, p. 152-158, 2009Tradução . . Disponível em: https://doi.org/10.1590/s0074-02762009000900021. Acesso em: 19 nov. 2024.
APA
Rassi Júnior, A., Rassi, A., & Marin Neto, J. A. (2009). Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Memórias do Instituto Oswaldo Cruz, 104, 152-158. doi:10.1590/s0074-02762009000900021
NLM
Rassi Júnior A, Rassi A, Marin Neto JA. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification [Internet]. Memórias do Instituto Oswaldo Cruz. 2009 ; 104 152-158.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1590/s0074-02762009000900021
Vancouver
Rassi Júnior A, Rassi A, Marin Neto JA. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification [Internet]. Memórias do Instituto Oswaldo Cruz. 2009 ; 104 152-158.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1590/s0074-02762009000900021
Artigo de periodico
Paediatrics and congenital heart disease in south America: an overview (2009)
Pedra, Carlos A. C; Haddad, Jorge; Pedra, Simone F.; Peirone, Alejandro; Pilla, Carlo B.; Marin Neto, Jose Antonio
Source: Heart. Unidade: FMRP
Assunto: CARDIOPATIAS CONGÊNITAS (TRATAMENTO;CIRURGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRA, Carlos A. C et al. Paediatrics and congenital heart disease in south America: an overview. Heart, v. 95, n. 17, p. 1385-1392, 2009Tradução . . Disponível em: https://doi.org/10.1136/hrt.2008.152017. Acesso em: 19 nov. 2024.
APA
Pedra, C. A. C., Haddad, J., Pedra, S. F., Peirone, A., Pilla, C. B., & Marin Neto, J. A. (2009). Paediatrics and congenital heart disease in south America: an overview. Heart, 95( 17), 1385-1392. doi:10.1136/hrt.2008.152017
NLM
Pedra CAC, Haddad J, Pedra SF, Peirone A, Pilla CB, Marin Neto JA. Paediatrics and congenital heart disease in south America: an overview [Internet]. Heart. 2009 ; 95( 17): 1385-1392.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1136/hrt.2008.152017
Vancouver
Pedra CAC, Haddad J, Pedra SF, Peirone A, Pilla CB, Marin Neto JA. Paediatrics and congenital heart disease in south America: an overview [Internet]. Heart. 2009 ; 95( 17): 1385-1392.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1136/hrt.2008.152017
Artigo de periodico
Evaluation of adult chronic chagas' heart disease diagnosis by molecular and serological methods (2009)
Ramírez, Juan David; Guhl, Felipe; Umezawa, Eufrosina Setsu; Morillo, Carlos A.; Rosas, Fernando; Marin Neto, Jose Antonio; Restrepo, Silvia
Source: Journal of Clinical Microbiology. Unidades: FM, FMRP
Assunto: DOENÇA DE CHAGAS (DIAGNÓSTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMÍREZ, Juan David et al. Evaluation of adult chronic chagas' heart disease diagnosis by molecular and serological methods. Journal of Clinical Microbiology, v. 47, n. 12, p. 3945-3951, 2009Tradução . . Acesso em: 19 nov. 2024.
APA
Ramírez, J. D., Guhl, F., Umezawa, E. S., Morillo, C. A., Rosas, F., Marin Neto, J. A., & Restrepo, S. (2009). Evaluation of adult chronic chagas' heart disease diagnosis by molecular and serological methods. Journal of Clinical Microbiology, 47( 12), 3945-3951.
NLM
Ramírez JD, Guhl F, Umezawa ES, Morillo CA, Rosas F, Marin Neto JA, Restrepo S. Evaluation of adult chronic chagas' heart disease diagnosis by molecular and serological methods. Journal of Clinical Microbiology. 2009 ; 47( 12): 3945-3951.[citado 2024 nov. 19 ]
Vancouver
Ramírez JD, Guhl F, Umezawa ES, Morillo CA, Rosas F, Marin Neto JA, Restrepo S. Evaluation of adult chronic chagas' heart disease diagnosis by molecular and serological methods. Journal of Clinical Microbiology. 2009 ; 47( 12): 3945-3951.[citado 2024 nov. 19 ]
Artigo de periodico
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease (2009)
Marin Neto, Jose Antonio; Rassi Junior, Anis; Avezum Júnior, Álvaro; Mattos, Antonio C.; Rassi, Anis
Source: Memórias do Instituto Oswaldo Cruz. Unidade: FMRP
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN NETO, Jose Antonio et al. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Memórias do Instituto Oswaldo Cruz, v. 104, p. 319-324, 2009Tradução . . Disponível em: https://doi.org/10.1590/s0074-02762009000900042. Acesso em: 19 nov. 2024.
APA
Marin Neto, J. A., Rassi Junior, A., Avezum Júnior, Á., Mattos, A. C., & Rassi, A. (2009). The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Memórias do Instituto Oswaldo Cruz, 104, 319-324. doi:10.1590/s0074-02762009000900042
NLM
Marin Neto JA, Rassi Junior A, Avezum Júnior Á, Mattos AC, Rassi A. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease [Internet]. Memórias do Instituto Oswaldo Cruz. 2009 ; 104 319-324.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1590/s0074-02762009000900042
Vancouver
Marin Neto JA, Rassi Junior A, Avezum Júnior Á, Mattos AC, Rassi A. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease [Internet]. Memórias do Instituto Oswaldo Cruz. 2009 ; 104 319-324.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1590/s0074-02762009000900042
Artigo de periodico
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in chagas' cardiomyopathy: the BENznidazole evaluation for interrupting trypanosomiasis (BENEFIT) (2008)
Marin-Neto, José Antônio
Source: American Heart Journal. Unidade: FMRP
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, MIOCARDIOPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in chagas' cardiomyopathy: the BENznidazole evaluation for interrupting trypanosomiasis (BENEFIT). American Heart Journal, v. 156, n. 1, p. 37-43, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2008.04.001. Acesso em: 19 nov. 2024.
APA
Marin-Neto, J. A. (2008). Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in chagas' cardiomyopathy: the BENznidazole evaluation for interrupting trypanosomiasis (BENEFIT). American Heart Journal, 156( 1), 37-43. doi:10.1016/j.ahj.2008.04.001
NLM
Marin-Neto JA. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in chagas' cardiomyopathy: the BENznidazole evaluation for interrupting trypanosomiasis (BENEFIT) [Internet]. American Heart Journal. 2008 ; 156( 1): 37-43.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.ahj.2008.04.001
Vancouver
Marin-Neto JA. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in chagas' cardiomyopathy: the BENznidazole evaluation for interrupting trypanosomiasis (BENEFIT) [Internet]. American Heart Journal. 2008 ; 156( 1): 37-43.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.ahj.2008.04.001
Artigo de periodico
Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN trial (outcome reduction with an initial glargine intervention) (2008)
Marin-Neto, José Antônio
Source: American Heart Journal. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN trial (outcome reduction with an initial glargine intervention). American Heart Journal, v. 155, n. 1, p. 26.e1-26.e13, 2008Tradução . . Acesso em: 19 nov. 2024.
APA
Marin-Neto, J. A. (2008). Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN trial (outcome reduction with an initial glargine intervention). American Heart Journal, 155( 1), 26.e1-26.e13.
NLM
Marin-Neto JA. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN trial (outcome reduction with an initial glargine intervention). American Heart Journal. 2008 ; 155( 1): 26.e1-26.e13.[citado 2024 nov. 19 ]
Vancouver
Marin-Neto JA. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN trial (outcome reduction with an initial glargine intervention). American Heart Journal. 2008 ; 155( 1): 26.e1-26.e13.[citado 2024 nov. 19 ]
Artigo de periodico
Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice (2008)
Pazin-Filho, Antônio; Marin-Neto, José Antônio
Source: American Journal of Cardiology. Unidade: FMRP
Subjects: ELETROCARDIOGRAFIA, PROGNÓSTICO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAZIN-FILHO, Antônio e MARIN-NETO, José Antônio. Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice. American Journal of Cardiology, v. 101, n. 7, p. 919-924, 2008Tradução . . Acesso em: 19 nov. 2024.
APA
Pazin-Filho, A., & Marin-Neto, J. A. (2008). Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice. American Journal of Cardiology, 101( 7), 919-924.
NLM
Pazin-Filho A, Marin-Neto JA. Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice. American Journal of Cardiology. 2008 ; 101( 7): 919-924.[citado 2024 nov. 19 ]
Vancouver
Pazin-Filho A, Marin-Neto JA. Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice. American Journal of Cardiology. 2008 ; 101( 7): 919-924.[citado 2024 nov. 19 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Indexado em

Non normalized affiliation